<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T04:53:45Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/30300" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/30300</identifier><datestamp>2026-09-24T05:51:31Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Britz-McKibbin, Philip</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Helmeczi, William (Erick)</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Chemical Biology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2024-10-02T14:51:09Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2024-10-02T14:51:09Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2024</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/30300</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/21415</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Vitamin D represents a group of pro-hormones with pleiotropic effects on human health that regulate calcium homeostasis, bone formation, immune function, and muscle protein turn-over. Despite the historic success of vitamin D3 to prevent nutritional rickets, vitamin D deficiency (VDD) remains a global health concern that disproportionately impacts vulnerable demographic groups, including critically ill children in pediatric intensive care units (PICUs) who are at greater risk for morbidity and mortality than vitamin D sufficient patients. This has recently inspired nutritional interventions using high-dose vitamin D3 supplementation as a safe, low-cost, and potentially efficacious treatment to improve the clinical outcomes of critically ill children with VDD, such as reduced illness severity, lower sepsis incidents, and earlier hospital discharge.&#xd;
This thesis will outline the development of new advances in high resolution mass spectrometry (MS)-based methods and data pre-processing tools for comprehensive metabolomic and lipidomic analyses that can support on-going vitamin D clinical trials that aim to shine greater light into the mechanisms and biological effects of the “sunshine vitamin” in high-risk critically ill children. Chapter II describes a high throughput “separation-free” assay for the rapid screening of vitamin D status in critically ill children based on direct infusion-tandem mass spectrometry (DI-MS/MS) in conjunction with pre-column chemical derivatization using 2-nitrosopyridine. This assay was extensively validated using certified reference samples for quality assurance and compared to both LC-MS/MS and a commercial competitive chemiluminescent immunoassay in PICU patients (n=30). The importance of high-throughput techniques in metabolomics is further highlighted in Chapter III, which focuses on the development of an automated data pre-processing tool for performing untargeted metabolite profiling (i.e., metabolomics) when using high throughput screening methods based on multisegment injection-capillary electrophoresis-mass spectrometry (MSI-CE-MS). Currently, manual data pre-processing techniques are required in metabolomic data workflows given the spectral complexity of multiplexed separations and the large migration time variability in MSI-CE-MS, which is time-consuming, resource intensive, and prone to bias. Herein, Chapter III introduces PeakMeister to accelerate data pre-processing when performing serum metabolomic analyses with MSI-CE-MS under positive ion mode that takes advantage of a robust peak detection strategy that relies on migration time indices that avoids complicated time warping and electrophoretic mobility transformations. MSI-CE-MS in conjunction with PeakMeister achieved excellent peak picking fidelity and integration accuracy that was 30-times faster than manual integration by an experienced analyst when analyzing over 5,000 serum samples from a Brazilian nutritional survey of young children/infants under 5 years of age. Lastly, the development of a reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) assay is described in Chapter IV, which can measure various vitamin D metabolites and their isomers in conjunction with untargeted lipidomic profiling to provide better insight into the treatment response differences of PICU patients with VDD following a single large bolus dose of up to 400,000 IU of vitamin D3 relative to placebo. MSI-CE-MS in conjunction with PeakMeister was also applied for untargeted serum metabolic profiling in this phase-II randomized clinical control trial involving a cohort of critically ill children (n=31). For the first time, Chapter IV reports the discovery of circulating 3-epi-D3 while also revealing that the 25-OH-D treatment response of supplemented critically ill children were modulated by differences in vitamin D3 bioavailability and C3-epimerase activity with evidence that individuals who attained vitamin D repletion (> 75 nmol/L) within 3 days had a metabolic phenotype consistent with lower oxidative stress, inflammation, and muscle wasting. As a whole, this thesis highlights the importance of rigorous analytical method validation from sample preparation to data pre-processing and contributes new advances to the field of precision nutrition to explain the conflicting results reported in high-dose vitamin D interventional trials.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Dissertation</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Candidate in Philosophy</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">COMPLEMENTARY MASS SPECTROMETRIC ASSAYS AND AUTOMATED DATA PRE-PROCESSING TOOLS IN METABOLOMICS FOR STUDYING VITAMIN D INTERVENTIONS IN CRITICALLY ILL CHILDREN</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>